| Zacks Company Profile for Electromed, Inc. (ELMD : AMEX) |
|
|
| |
| • Company Description |
| Electromed, Inc. manufactures, markets and sells products that provide airway clearance therapy to patients with compromised pulmonary function. The Company is the designer, manufacturer and worldwide provider of the SmartVest? Airway Clearance System and related products. The patented system uses High Frequency Chest Wall Oscillation (HFCWO), an alternative to Chest Physiotherapy (CPT), to deliver airway clearance treatment. The Company manufactures its products for use by chronically-ill patients who face health risks due to pneumonia and mucus accumulation in the lungs, particularly patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company's products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota.
Number of Employees: 174 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $20.01 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 116,270 shares |
| Shares Outstanding: 8.39 (millions) |
| Market Capitalization: $167.81 (millions) |
| Beta: 0.41 |
| 52 Week High: $35.56 |
| 52 Week Low: $13.74 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
0.00% |
-3.74% |
| 12 Week |
-12.20% |
-26.15% |
| Year To Date |
-32.28% |
-36.58% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
James L. Cunniff - Chief Executive Officer and President
Bradley M. Nagel - Chief Financial Officer
Stan K. Erickson - Director
Gregory J. Fluet - Director
Joseph L. Galatowitsch - Director
|
|
Peer Information
Electromed, Inc. (ABMD)
Electromed, Inc. (DMDS)
Electromed, Inc. (CPWY.)
Electromed, Inc. (EQUR)
Electromed, Inc. (ECIA)
Electromed, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 285409108
SIC: 3845
|
|
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/26/25
|
|
Share - Related Items
Shares Outstanding: 8.39
Most Recent Split Date: (:1)
Beta: 0.41
Market Capitalization: $167.81 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $0.20 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $1.00 |
Payout Ratio: 0.00 |
| Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: 0.00 |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/26/25 |
|
|
|
| |
